Atamestane (developmental code name SH-489), also known as metandroden, as well as 1-methylandrosta-1,4-diene-3,17-dione, is a steroidal aromatase inhibitor that was studied in the treatment of cancer.
It blocks the production of estrogen in the body. The drug is selective, competitive, and irreversible in its enzyme inhibitor, inhibition of aromatase.
See also
* Boldione (androsta-1,4-diene-3,17-dione)
References
External links
Atamestaneentry in the public domain NCI Dictionary of Cancer Terms
Androgens and anabolic steroids
Androstanes
Aromatase inhibitors
Enantiopure drugs
{{antineoplastic-drug-stub